FDA Warns of Correlation Between All Breast Implants and Large Cell Lymphoma




WASHINGTON, D.C. — The Food and Drug Administration has warned health care providers of an association between all breast implants, regardless of filling or texture, and breast implant associated-anaplastic large cell lymphoma (BIA-ALCL).

In a Feb. 6 “Dear Healthcare Provider” letter, the agency says it received reports that patients with breast implants have an increased risk of developing this disease within the scar capsule adjacent to the implant.

“BIA-ALCL is a type of lymphoma and is not a cancer of the breast tissue,” the letter says. “When breast implants are placed in the body, they are inserted behind the …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS